{"id":59419,"date":"2026-02-26T19:58:33","date_gmt":"2026-02-26T19:58:33","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/red-biotechnology-market-mordor\/"},"modified":"2026-09-04T07:41:29","modified_gmt":"2026-09-03T22:41:29","slug":"red-biotechnology-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/red-biotechnology-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \ubd89\uc740 \uc0dd\uba85\uacf5\ud559 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/red-biotechnology-market-1750295142806-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/red-biotechnology-market-size-image-1770825606678.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \ub9cc\uc131 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \ubc1c\uc0dd\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc758\ub8cc \uc790\uae08 \ud655\ub300 \ubc0f \ubbfc\uad00 \ud611\ub825<\/li>\n<li class=\"toc-level-3\">4.2.3 \ub9de\ucda4\ud615 \uc758\ud559 \ucc44\ud0dd \ubc0f \ub3d9\ubc18 \uc9c4\ub2e8 \ud65c\uc6a9 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.4 mRNA \ud50c\ub7ab\ud3fc\uc758 \ud30c\uae09 \ud6a8\uacfc\ub85c \uc2e0\uaddc \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uac1c\ubc1c \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.5 AI \uae30\ubc18 \ucd08\uae30 \ub2e8\uacc4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc124\uacc4 \uc704\ud5d8 \uac10\uc18c<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc815\ubd80 \uc8fc\ub3c4 \ud32c\ub370\ubbf9 \ub300\ube44 \ud504\ub85c\uadf8\ub7a8\uc73c\ub85c \uae00\ub85c\ubc8c \ubc31\uc2e0 \uc81c\uc870 \uc5ed\ub7c9 \ud655\ub300<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \ubc14\uc774\uc624 \uc81c\uc870 \ubc0f \ucf5c\ub4dc\uccb4\uc778 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \ubcf5\uc7a1\ud558\uace0 \ubcc0\ud654\ud558\ub294 \uae00\ub85c\ubc8c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uaddc\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.3 \ud575\uc2ec \uc6d0\uc790\uc7ac \uacf5\uae09\ub9dd \ucde8\uc57d\uc131<\/li>\n<li class=\"toc-level-3\">4.3.4 \ucc28\uc138\ub300 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \uba74\uc5ed\uc6d0\uc131 \uc704\ud5d8<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \ubc31\uc2e0<\/li>\n<li class=\"toc-level-4\">5.1.1.1 mRNA \ubc31\uc2e0<\/li>\n<li class=\"toc-level-4\">5.1.1.2 \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130 \ubc31\uc2e0<\/li>\n<li class=\"toc-level-4\">5.1.1.3 \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8 \ubc31\uc2e0<\/li>\n<li class=\"toc-level-4\">5.1.1.4 \uc811\ud569 &amp; \uc11c\ube0c\uc720\ub2db \ubc31\uc2e0<\/li>\n<li class=\"toc-level-4\">5.1.1.5 \uc57d\ub3c5\ud654 \uc0dd\ubc31\uc2e0 &amp; \ubd88\ud65c\ud654 \ubc31\uc2e0<\/li>\n<li class=\"toc-level-3\">5.1.2 \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-4\">5.1.2.1 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4<\/li>\n<li class=\"toc-level-4\">5.1.2.2 \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8<\/li>\n<li class=\"toc-level-4\">5.1.2.3 \uc720\uc804\uc790 \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-4\">5.1.2.4 \uc138\ud3ec \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-4\">5.1.2.5 RNA \uce58\ub8cc\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc9c4\ub2e8 &amp; \uc5f0\uad6c \ub3c4\uad6c<\/li>\n<li class=\"toc-level-4\">5.1.3.1 \uc2dc\ud000\uc2f1 \uc2dc\uc57d &amp; \ud0a4\ud2b8<\/li>\n<li class=\"toc-level-4\">5.1.3.2 \ub3d9\ubc18 \uc9c4\ub2e8 \ubd84\uc11d<\/li>\n<li class=\"toc-level-4\">5.1.3.3 \ud604\uc7a5 \ubd84\uc790 \uac80\uc0ac<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ubc14\uc774\uc624\uc81c\uc57d \ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc704\ud0c1 \uc0dd\uc0b0 \uae30\uad00 (CMO)<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc704\ud0c1 \uc5f0\uad6c \uae30\uad00 (CRO)<\/li>\n<li class=\"toc-level-3\">5.2.4 \ud559\uc220 &amp; \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.2.5 \ubcd1\uc6d0 &amp; \uc804\ubb38 \ud074\ub9ac\ub2c9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uacbd\uc7c1 \ubca4\uce58\ub9c8\ud0b9<\/li>\n<li class=\"toc-level-2\">6.3 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.4 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.4.1 Amgen Inc.<\/li>\n<li class=\"toc-level-3\">6.4.2 AstraZeneca PLC<\/li>\n<li class=\"toc-level-3\">6.4.3 Biogen Inc.<\/li>\n<li class=\"toc-level-3\">6.4.4 BioNTech SE<\/li>\n<li class=\"toc-level-3\">6.4.5 Bristol Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.4.6 CSL Limited<\/li>\n<li class=\"toc-level-3\">6.4.7 F. Hoffmann-La Roche Ltd<\/li>\n<li class=\"toc-level-3\">6.4.8 Gilead Sciences Inc.<\/li>\n<li class=\"toc-level-3\">6.4.9 Illumina Inc.<\/li>\n<li class=\"toc-level-3\">6.4.10 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.4.11 Lonza Group AG<\/li>\n<li class=\"toc-level-3\">6.4.12 Merck &amp; Co., Inc.<\/li>\n<li class=\"toc-level-3\">6.4.13 Moderna Inc.<\/li>\n<li class=\"toc-level-3\">6.4.14 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.4.15 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.4.16 Regeneron Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.4.17 Sanofi<\/li>\n<li class=\"toc-level-3\">6.4.18 Sarepta Therapeutics<\/li>\n<li class=\"toc-level-3\">6.4.19 Takeda Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.4.20 Thermo Fisher Scientific<\/li>\n<li class=\"toc-level-3\">6.4.21 Vertex Pharmaceuticals<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc804\ub9dd \ubcf4\uace0\uc11c (2026-2031) \uc694\uc57d<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \ud1b5\uacc4<\/p>\n<p>\ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5\uc740 2025\ub144 5,356\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 7,614\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.05%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \ud32c\ub370\ubbf9 \uc911\uc2ec\uc758 \ubc31\uc2e0 \uc0dd\uc0b0\uc5d0\uc11c \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c, \ucc28\uc138\ub300 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4, \uc815\ubc00 \uc9c4\ub2e8 \ub4f1 \ub2e4\uac01\ud654\ub41c \ud30c\uc774\ud504\ub77c\uc778\uc73c\ub85c\uc758 \uc804\ud658\uc5d0 \ud06c\uac8c \uae30\uc778\ud569\ub2c8\ub2e4. \ubbf8\uad6d FDA\uc758 2024\ub144 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ud5c8\uac00 24\uac74\uacfc 2027\ub144\uae4c\uc9c0 795\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uacf5\uc911 \ubcf4\uac74 \ube44\uc0c1 \uc758\ub8cc \ub300\ucc45 \uae30\uc5c5(PHEMCE) \uc608\uc0b0 \ubc30\uc815 \ub4f1 \uc2e0\uc18d\ud55c \uaddc\uc81c \uac80\ud1a0\uc640 \uc815\ubd80 \uc9c0\ucd9c \ud655\ub300\uac00 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ub4b7\ubc1b\uce68\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uba38\ud06c(Merck)\uc758 10\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 \ubc31\uc2e0 \uc2dc\uc124 \ud22c\uc790\uc640 \uac19\uc740 \uc0b0\uc5c5\uacc4\uc758 \ub300\uaddc\ubaa8 \uc790\ubcf8 \ud504\ub85c\uc81d\ud2b8\ub294 \ud32c\ub370\ubbf9 \ub300\uc751\uacfc \uc0c1\uc5c5\uc801 \uc0dd\uc0b0 \ubaa8\ub450\uc5d0 \uc720\uc5f0\ud558\uac8c \ub300\uc751\ud560 \uc218 \uc788\ub294 \uc0dd\uc0b0 \uc5ed\ub7c9\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc694\uc18c\ub4e4\uc740 \uace0\ubcf5\uc7a1\uc131 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uaddc\ubaa8 \ud655\uc7a5\uc744 \uc704\ud55c \uc608\uce21 \uac00\ub2a5\ud55c \ud658\uacbd\uc744 \uc870\uc131\ud558\uc5ec, \ud601\uc2e0\uc801\uc778 \uc790\uc0b0\uc758 \uc784\uc0c1 \uc9c4\uc785 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\ub294 \ubca4\ucc98 \ud22c\uc790 \ubc0f \ubbfc\uad00 \ud30c\ud2b8\ub108\uc2ed\uc744 \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d:<br \/>\n*   \uc81c\ud488 \uce74\ud14c\uace0\ub9ac: \uce58\ub8cc\uc6a9 \uc758\uc57d\ud488(Therapeutic Drugs) \ubd80\ubb38\uc740 2025\ub144 \ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 54.12%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 6.63%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790: \ubc14\uc774\uc624\uc81c\uc57d \uae30\uc5c5(Biopharmaceutical Companies)\uc774 2025\ub144 \uc2dc\uc7a5\uc758 44.25%\ub97c \uc810\uc720\ud588\uc73c\ub098, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00(Academic &#038; Research Institutes)\uc774 2031\ub144\uae4c\uc9c0 7.05%\ub85c \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed: \ubd81\ubbf8(North America)\uac00 2025\ub144 \ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5\uc758 38.72%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc774\uc5c8\uace0, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(Asia-Pacific) \uc9c0\uc5ed\uc740 \uac19\uc740 \uae30\uac04 \ub3d9\uc548 6.94%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4.<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04(Medium) \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p># 2. \uae00\ub85c\ubc8c \ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p> 2.1. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825 (Drivers)<\/p>\n<p>*   \ub9cc\uc131 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \ubc1c\uc0dd\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00 (+1.2% CAGR \uc601\ud5a5): 2024\ub144 FDA\uac00 \uc2b9\uc778\ud55c 8\uac1c\uc758 \uc0c8\ub85c\uc6b4 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub294 \ubbf8\ucda9\uc871 \uc758\ub8cc \uc218\uc694\uac00 \uacfc\ud559\uc801 \ub3cc\ud30c\uad6c\ub97c \uc0c1\uc5c5\uc801 \uc790\uc0b0\uc73c\ub85c \uc804\ud658\uc2dc\ud0a4\ub294 \uacfc\uc815\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ud2b9\ud788 \uc885\uc591\ud559 \ubd84\uc57c\uac00 \uc2b9\uc778\uc758 34%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc77c\ubcf8\uacfc \uac19\uc740 \uace0\ub839\ud654 \uc778\uad6c \uad6d\uac00\uc5d0\uc11c\ub294 \ucc28\uc138\ub300 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4 \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc5d0 \ub300\ud55c \uc815\ucc45\uc801 \uc6b0\uc120\uc21c\uc704\ub97c \ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud76c\uadc0 \uc758\uc57d\ud488 \uc9c0\uc815 \uc778\uc13c\ud2f0\ube0c\ub294 \ud76c\uadc0 \uc9c8\ud658 \ud30c\uc774\ud504\ub77c\uc778 \uac1c\ubc1c\uc744 \ucd09\uc9c4\ud558\uba70, 2024\ub144 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc2b9\uc778\uc758 88%\uac00 \uc774 \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc758\ub8cc \uc790\uae08 \ud655\ub300 \ubc0f \ubbfc\uad00 \ud30c\ud2b8\ub108\uc2ed (+0.9% CAGR \uc601\ud5a5): 2023-2027\ub144 PHEMCE \uc608\uc0b0\uc740 \ub300\ucc45 R&#038;D \ubc0f \uad6d\ub0b4 \uc81c\uc870\ub97c \uc704\ud574 795\uc5b5 \ub2ec\ub7ec\uac00 \ubc30\uc815\ub418\uc5c8\uc73c\uba70, \uc774\ub294 \uc774\uc804 \uacc4\ud68d \uc8fc\uae30\ubcf4\ub2e4 155\uc5b5 \ub2ec\ub7ec \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. BARDA\uc758 20\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8 BioMaP \ucee8\uc18c\uc2dc\uc5c4\uc740 \ud56d\uccb4\uc5d0\uc11c mRNA \ubc31\uc2e0\uc73c\ub85c \uc218\uac1c\uc6d4 \ub0b4 \uc804\ud658 \uac00\ub2a5\ud55c \uc720\uc5f0\ud55c \uc2dc\uc124\uc5d0 \uacf5\ub3d9 \ud22c\uc790\ud558\uc5ec \uc774\ub7ec\ud55c \uc9c0\uc6d0\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc720\ub7fd\uc5f0\ud569 \uc9d1\ud589\uc704\uc6d0\ud68c(European Commission)\uc758 GenAI4EU \ud504\ub85c\uadf8\ub7a8\uc740 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc1c\uacac\uc744 \ud3ec\ud568\ud55c AI \ud504\ub85c\uc81d\ud2b8\uc5d0 10\uc5b5 \uc720\ub85c\ub97c \ud560\ub2f9\ud558\uc5ec \uad6d\uacbd\uc744 \ucd08\uc6d4\ud55c \uc9c0\uc2dd \uc774\uc804\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uac1c\uc778 \ub9de\ucda4\ud615 \uc758\ud559 \ucc44\ud0dd \ubc0f \ub3d9\ubc18 \uc9c4\ub2e8(CDx)\uc758 \uc99d\ub300 (+0.8% CAGR \uc601\ud5a5): 2025\ub144 FDA \uc9c0\uce68\uc740 AI\uac00 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc5d0 \ub300\ud55c \uaddc\uc81c \uc758\uc0ac\uacb0\uc815\uc744 \uc5b4\ub5bb\uac8c \uac15\ud654\ud560 \uc218 \uc788\ub294\uc9c0 \uba85\ud655\ud788 \ud558\uc5ec, \uba38\uc2e0\ub7ec\ub2dd \uae30\ubc18 \ub3d9\ubc18 \uc9c4\ub2e8\uc758 \uacf5\uc2dd\uc801\uc778 \uc218\uc6a9\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \uc720\uc804\uc790 \uac80\uc0ac\ub294 \ud604\uc7ac \uc0c1\uc5c5\uc6a9 \uc815\ubc00 \uc9c4\ub2e8 \ud0a4\ud2b8\uc758 45%\ub97c \ucc28\uc9c0\ud558\uba70, \uc885\uc591\ud559 \ubd84\uc57c\uac00 \uc804\uccb4 \uc218\uc694\uc758 4\ubd84\uc758 1\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. \ucc28\uc138\ub300 \uc5fc\uae30\uc11c\uc5f4 \ubd84\uc11d(NGS)\uc758 \uc811\uadfc\uc131 \ud655\ub300\ub294 \uc720\uc804\uccb4\ub2f9 \ube44\uc6a9\uc744 \ub0ae\ucdb0 \uc911\uc18c\ud615 \ubc14\uc774\uc624\uc81c\uc57d \uae30\uc5c5\ub3c4 \uc608\uc0b0 \ubd80\ub2f4 \uc5c6\uc774 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uacc4\uce35\ud654\ud560 \uc218 \uc788\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   mRNA \ud50c\ub7ab\ud3fc\uc758 \ud30c\uae09 \ud6a8\uacfc\ub85c \uc778\ud55c \uc2e0\uaddc \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uac1c\ubc1c \uac00\uc18d\ud654 (+0.7% CAGR \uc601\ud5a5): 2024\ub144 6\uc6d4 \ud604\uc7ac, COVID-19 \uc678\uc5d0\ub3c4 \uc885\uc591\ud559, RSV, \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d\uc744 \ub300\uc0c1\uc73c\ub85c \ud558\ub294 70\uac1c\uc758 mRNA \uae30\ubc18 \ubc31\uc2e0 \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc9c4\ud589 \uc911\uc785\ub2c8\ub2e4. \ud2b8\ub79c\uc2a4 \uc99d\ud3ed \uad6c\uc870\ub294 RNA \ud22c\uc785\ub7c9\uc744 40\ubc30 \uc904\uc5ec \uba74\uc5ed\uc6d0\uc131\uc744 \uc720\uc9c0\ud558\uba74\uc11c \uc0dd\uc0b0 \ube44\uc6a9\uc744 \ub0ae\ucda5\ub2c8\ub2e4. \ubaa8\ub354\ub098(Moderna)\ub294 \uc601\uad6d, \ud638\uc8fc, \uce90\ub098\ub2e4\uc5d0 \uac01\uac01 1\uc5b5 \ub3c4\uc2a4 \uc0c1\ub2f9\uc758 \uc0dd\uc0b0 \ub2a5\ub825\uc744 \uac16\ucd98 3\uac1c\uc758 \uc9c0\uc5ed \uacf5\uc7a5\uc744 \uac74\uc124\ud558\uc5ec \uc2e0\uc18d\ud55c mRNA \ud30c\uc774\ud504\ub77c\uc778\uc758 \uae00\ub85c\ubc8c \ud655\uc7a5\uc131\uc744 \uc785\uc99d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \ucd08\uae30 \ub2e8\uacc4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc124\uacc4 \uc704\ud5d8 \uac10\uc18c (+0.6% CAGR \uc601\ud5a5): AI\ub294 \ud601\uc2e0 \uc13c\ud130\ub97c \uc911\uc2ec\uc73c\ub85c \ucd08\uae30 \ub2e8\uacc4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc124\uacc4\uc758 \uc704\ud5d8\uc744 \uc904\uc5ec \uac1c\ubc1c \uacfc\uc815\uc744 \ud6a8\uc728\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc815\ubd80 \uc8fc\ub3c4 \ud32c\ub370\ubbf9 \ub300\ube44 \ud504\ub85c\uadf8\ub7a8\uc73c\ub85c \uc778\ud55c \uae00\ub85c\ubc8c \ubc31\uc2e0 \uc81c\uc870 \uc5ed\ub7c9 \ud655\ub300 (+0.5% CAGR \uc601\ud5a5): \uac01\uad6d \uc815\ubd80\ub294 \uad6d\ub0b4 \uc5ed\ub7c9 \uac15\ud654\uc5d0 \uc911\uc810\uc744 \ub450\uace0 \ud32c\ub370\ubbf9 \ub300\ube44 \ud504\ub85c\uadf8\ub7a8\uc744 \ud1b5\ud574 \ubc31\uc2e0 \uc81c\uc870 \uc5ed\ub7c9\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p> 2.2. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778 (Restraints)<\/p>\n<p>*   \ub192\uc740 \ubc14\uc774\uc624 \uc81c\uc870 \ubc0f \ucf5c\ub4dc\uccb4\uc778 \ube44\uc6a9 (-0.8% CAGR \uc601\ud5a5): \ucf5c\ub4dc\uccb4\uc778 \uc2e4\ud328\ub85c \uc778\ud55c \uc0b0\uc5c5 \uc190\uc2e4\uc740 \uc5f0\uac04 350\uc5b5 \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uba70, \uc628\ub3c4\uc5d0 \ubbfc\uac10\ud55c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uacbd\uc81c\uc131\uc744 \uc57d\ud654\uc2dc\ud0b5\ub2c8\ub2e4. CAR-T \uc790\uac00 \uce58\ub8cc\uc81c\ub294 \ub178\ub3d9 \uc9d1\uc57d\uc801\uc778 \uc81c\uc870 \ubc0f \uadf9\uc800\uc628 \uc720\ud1b5\uc73c\ub85c \uc778\ud574 \ud658\uc790\ub2f9 50\ub9cc \ub2ec\ub7ec \uc774\uc0c1\uc758 \ube44\uc6a9\uc774 \ub4ed\ub2c8\ub2e4. \ub610\ud55c, \ubbf8\uad6d API \uc218\uc785\uc758 75% \uc774\uc0c1\uc774 \ud574\uc678\uc5d0\uc11c \ubc1c\uc0dd\ud558\uc5ec \uc9c0\uc815\ud559\uc801 \ucda9\uaca9\uc5d0 \ub300\ud55c \uc0dd\uc0b0 \ucde8\uc57d\uc131\uc744 \ub178\ucd9c\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubcf5\uc7a1\ud558\uace0 \ubcc0\ud654\ud558\ub294 \uae00\ub85c\ubc8c \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uaddc\uc81c (-0.6% CAGR \uc601\ud5a5): 2025\ub144 1\uc6d4 \ubc1c\ud6a8\ub41c EU \uc784\uc0c1 \uc2dc\ud5d8 \uaddc\uc815\uc740 \uc2a4\ud3f0\uc11c\uac00 \uae30\uc874 \uc5f0\uad6c \ub370\uc774\ud130\ub97c \uc0c8\ub85c\uc6b4 CTIS \ud3ec\ud138\uc5d0 \uc5c5\ub85c\ub4dc\ud558\ub3c4\ub85d \uc758\ubb34\ud654\ud558\uc5ec \ud589\uc815\uc801 \uc9c0\uc5f0\uc744 \ucd08\ub798\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. EMA \uc218\uc218\ub8cc \uac1c\ud3b8\uc73c\ub85c \uacfc\ud559\uc801 \uc790\ubb38 \ube44\uc6a9\uc774 \ucd5c\ub300 98,400\uc720\ub85c\uae4c\uc9c0 \uc0c1\uc2b9\ud558\uc5ec \uc18c\uaddc\ubaa8 \uac1c\ubc1c\uc0ac\uc5d0 \ubd80\ub2f4\uc744 \uc8fc\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d\uc5d0\uc11c\ub294 2025\ub144 6\uc6d4 \ubaa8\ub4e0 \uc608\ubc29\uc811\uc885\uc790\ubb38\uc704\uc6d0\ud68c(ACIP) \uc704\uc6d0 \uad50\uccb4\uac00 \uc608\uc815\ub418\uc5b4 \uc788\uc5b4 \ud5a5\ud6c4 \ubc31\uc2e0 \uc815\ucc45 \uc77c\uc815\uc5d0 \ubd88\ud655\uc2e4\uc131\uc744 \ub354\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud575\uc2ec \uc6d0\uc790\uc7ac \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131 (-0.5% CAGR \uc601\ud5a5): \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uacf5\uae09\uc5c5\uccb4\uc5d0 \uc9d1\uc911\ub41c \uacf5\uae09\ub9dd \uc704\ud5d8\uc740 \ud575\uc2ec \uc6d0\uc790\uc7ac\uc758 \uc548\uc815\uc801\uc778 \uacf5\uae09\uc744 \uc704\ud611\ud569\ub2c8\ub2e4.<br \/>\n*   \ucc28\uc138\ub300 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc758 \uba74\uc5ed\uc6d0\uc131 \uc704\ud5d8 (-0.4% CAGR \uc601\ud5a5): \ucc28\uc138\ub300 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub294 \uba74\uc5ed\uc6d0\uc131 \uc704\ud5d8\uc744 \ub0b4\ud3ec\ud558\uace0 \uc788\uc5b4, \ud2b9\ud788 \ubd81\ubbf8\uc640 \uc720\ub7fd\uc5d0\uc11c \ub192\uc740 \uc218\uc900\uc758 \uac80\ud1a0\ub97c \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 3. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p> 3.1. \uc81c\ud488\ubcc4 \ubd84\uc11d: \uce58\ub8cc\uc6a9 \uc758\uc57d\ud488\uc774 \ud601\uc2e0\uc744 \uc8fc\ub3c4<\/p>\n<p>\uc81c\ud488 \ubd80\ubb38\uc5d0\uc11c \uce58\ub8cc\uc6a9 \uc758\uc57d\ud488(Therapeutic Drugs)\uc740 2025\ub144 2,897\uc5b5 6\ucc9c\ub9cc \ub2ec\ub7ec\ub97c \uae30\ub85d\ud558\uba70 \ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5\uc758 54.12%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 2031\ub144\uae4c\uc9c0 6.63%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4\ub294 200\uac1c \uc774\uc0c1\uc758 \uc2b9\uc778\ub41c \uc81c\uc81c\uc640 1,400\uac1c\uc5d0 \uac00\uae4c\uc6b4 \uc784\uc0c1 \ud6c4\ubcf4 \ubb3c\uc9c8\ub85c \uc774 \ubd80\ubb38\uc758 \ud575\uc2ec\uc744 \uc774\ub8f9\ub2c8\ub2e4. \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4\ub294 \uac00\uc7a5 \ub192\uc740 \uc784\uc0c1-\uc2b9\uc778 \uc804\ud658\uc728\uc744 \ubcf4\uc774\uba70, \ubc14\uc774\uc624\uc5d4\ud14d(BioNTech)\uacfc \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb)\uacfc \uac19\uc740 \uae30\uc5c5\ub4e4\uc774 \uc218\uc2ed\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uacf5\ub3d9 \uac1c\ubc1c \uacc4\uc57d\uc744 \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub294 2024\ub144 FDA\uc758 8\uac1c \uc81c\ud488 \uc2b9\uc778 \uc774\ud6c4 \uac00\uc18d\ud654\ub418\uc5c8\uc73c\uba70, CRISPR \ubcc0\ud615 CAR-T \ud50c\ub7ab\ud3fc\uc740 \ucd08\uae30 \ub2e8\uacc4 \ud608\uc561\uc554 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. mRNA \uce58\ub8cc\uc81c\ub294 \uac10\uc5fc\uc131 \uc9c8\ud658\uc744 \ub118\uc5b4 \uc2ec\ud608\uad00 \ub300\uc0ac \uc9c8\ud658\uc73c\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc73c\uba70, \uc0dd\uccb4 \ub0b4 \ub2e8\ubc31\uc9c8 \uc218\uc728\uc744 \ub192\uc774\ub294 \uc6d0\ud615 RNA \uae30\uc220\uc758 \uc9c0\uc6d0\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc31\uc2e0(Vaccines)\uc740 \ubc1c\ubcd1 \uc2dc \ucd5c\uc18c \uc8fc\ubb38\ub7c9\uc744 \ubcf4\uc7a5\ud558\ub294 BARDA \uc635\uc158 \uc870\ud56d\uc5d0 \ud798\uc785\uc5b4 \uc804\ub7b5\uc801 \uc911\uc694\uc131\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc9c4\ub2e8 \ubc0f \uc5f0\uad6c \ub3c4\uad6c(Diagnostics &#038; Research Tools)\ub294 \uc5fc\uae30\uc11c\uc5f4 \ubd84\uc11d \uc2dc\uc57d\uacfc \uc561\uccb4 \uc0dd\uac80 \ubd84\uc11d\ubc95\uc774 \ubd84\uc0b0\ub41c \ud658\uacbd\uc5d0\uc11c \ucc44\ud0dd\ub418\uba74\uc11c \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub3d9\uc2dc\uc5d0 \uce58\ub8cc\uc6a9 \ub2e8\ubc31\uc9c8\uc740 \ud2b9\uc815 \uc9c8\ubcd1 \ubbf8\uc138 \ud658\uacbd\uc5d0 \ub9de\ucda4\ud654\ub41c \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC) \ubc0f \uc735\ud569 \uc0ac\uc774\ud1a0\uce74\uc778\uc73c\ub85c \uc9c4\ud654\ud558\uba70 \uc815\ubc00 \ud45c\uc801\ud654\uc5d0 \ub300\ud55c \ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5\uc758 \uac15\uc870\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4.<\/p>\n<p> 3.2. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4 \ubd84\uc11d: \ud559\uc220 \ud30c\ud2b8\ub108\uc2ed\uc774 \uc131\uc7a5\uc744 \uacac\uc778<\/p>\n<p>\ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubd80\ubb38\uc5d0\uc11c \ubc14\uc774\uc624\uc81c\uc57d \uae30\uc5c5(Biopharmaceutical Companies)\uc740 \ubc1c\uacac\ubd80\ud130 \uc0c1\uc5c5\uc801 \uacf5\uae09\uc5d0 \uc774\ub974\ub294 \uc218\uc9c1\uc801 \ud1b5\ud569\uc744 \ud1b5\ud574 2025\ub144 \ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 44.25%\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00(Academic &#038; Research Institutes)\uc740 \ubcf4\uc870\uae08 \uc720\uc785\uacfc \uc8fc\uc694 \uc5f0\uad6c\uc790\ub4e4\uc758 \uae30\uc5c5 \uacf5\ub3d9 \ucc44\uc6a9\uc5d0 \ud798\uc785\uc5b4 7.05%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc8fc\uccb4\uc785\ub2c8\ub2e4. \ub300\ud559 \ud575\uc2ec \uc2dc\uc124\uc740 \uc774\uc81c GMP(Good Manufacturing Practice) \uc900\uc218 \ubca1\ud130 \uc2a4\uc704\ud2b8\ub97c \uc81c\uacf5\ud558\uc5ec \uc2a4\ud540\uc544\uc6c3 \uae30\uc5c5\ub4e4\uc774 \uc804\uc6a9 \uc778\ud504\ub77c \uad6c\ucd95 \uc5c6\uc774 \ucd08\uae30 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc218\ud589\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4. \uc5d4\ube44\ub514\uc544(NVIDIA)\uc640 \ub178\ubcf4 \ub178\ub514\uc2a4\ud06c(Novo Nordisk)\uc758 \uc81c\ud734\ub294 100\uac1c \uc774\uc0c1\uc758 \ud559\uc220 \uc5f0\uad6c\uc2e4\uc5d0 \ud074\ub77c\uc6b0\ub4dc GPU \ud06c\ub808\ub527\uacfc \uad6c\uc870 \uc608\uce21 \uc54c\uace0\ub9ac\uc998\uc744 \uc81c\uacf5\ud558\uc5ec AI \uc124\uacc4 \ub3c4\uad6c\uc5d0 \ub300\ud55c \uc811\uadfc\uc131\uc744 \ubbfc\uc8fc\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc704\ud0c1\uc0dd\uc0b0\uae30\uad00(CMO)\uacfc \uc704\ud0c1\uc5f0\uad6c\uae30\uad00(CRO)\ub3c4 \uc544\uc6c3\uc18c\uc2f1\uc774 \uc790\ubcf8 \ubd80\ub2f4\uc744 \uc644\ud654\ud568\uc5d0 \ub530\ub77c \ubcd1\ud589 \uc131\uc7a5\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. CMO\ub294 2028\ub144\uae4c\uc9c0 \uc804 \uc138\uacc4 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \uc0dd\uc0b0 \ub2a5\ub825\uc758 54%\ub97c \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc18c\uaddc\ubaa8 \ud601\uc2e0 \uae30\uc5c5\uc758 \uc790\uccb4 \uc0dd\uc0b0 \ub300 \uc704\ud0c1 \uc0dd\uc0b0 \uacb0\uc815\uc744 \uc7ac\ud3b8\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcd1\uc6d0\ubcd1\uc6d0\uc740 \uc784\uc0c1 \uc2dc\ud5d8\uc758 \uc8fc\uc694 \uac70\uc810\uc73c\ub85c\uc11c, \uc2e0\uc57d \ubc0f \ucca8\ub2e8 \uce58\ub8cc\ubc95\uc758 \uac1c\ubc1c\uacfc \uc0c1\uc6a9\ud654\uc5d0 \ud544\uc218\uc801\uc778 \uc5ed\ud560\uc744 \uc218\ud589\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc640 \uac19\uc740 \ubcf5\uc7a1\ud55c \ubc14\uc774\uc624 \uc758\uc57d\ud488\uc758 \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc99d\uac00\ud568\uc5d0 \ub530\ub77c, \uc804\ubb38\ud654\ub41c \uc778\ud504\ub77c\uc640 \uc219\ub828\ub41c \uc758\ub8cc\uc9c4\uc744 \uac16\ucd98 \ubcd1\uc6d0\uc758 \uc911\uc694\uc131\uc774 \ub354\uc6b1 \ucee4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ubcd1\uc6d0\ub4e4\uc740 \ud658\uc790 \ubaa8\uc9d1, \uce58\ub8cc \ud504\ub85c\ud1a0\ucf5c \uc900\uc218, \uadf8\ub9ac\uace0 \uc784\uc0c1 \ub370\uc774\ud130 \uad00\ub9ac\uc5d0 \uc788\uc5b4 \ud575\uc2ec\uc801\uc778 \uc5ed\ud560\uc744 \ub2f4\ub2f9\ud558\uba70, \uc804\uccb4 \ubc14\uc774\uc624 \uc81c\uc57d \uc0dd\ud0dc\uacc4\uc758 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc778\uac04 \uc9c8\ubcd1\uc758 \uce58\ub8cc, \uc9c4\ub2e8, \uc608\ubc29\uc744 \uc704\ud574 \uc0b4\uc544\uc788\ub294 \uc138\ud3ec, \uc870\uc791\ub41c \uc720\uae30\uccb4 \ub610\ub294 \uadf8 \ud30c\uc0dd\ubb3c\uc744 \ud65c\uc6a9\ud558\ub294 \uce58\ub8cc\uc6a9 \ubc14\uc774\uc624\uc758\uc57d\ud488, \uc608\ubc29 \ubc31\uc2e0, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uae30\ubc18 \uc758\uc57d\ud488, \ubd84\uc790 \uc9c4\ub2e8\uc744 \ud3ec\ud568\ud558\ub294 &#8216;\ub808\ub4dc \ubc14\uc774\uc624\uae30\uc220 \uc2dc\uc7a5&#8217;\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc0b0\uc5c5\uc6a9 \ud6a8\uc18c, \ub18d\uc5c5\uc6a9 \ubc14\uc774\uc624\uae30\uc220 \ud22c\uc785\ubb3c, \ud658\uc790 \uce58\ub8cc\uc640 \ubb34\uad00\ud55c \uc0dd\uccb4 \uc7ac\ub8cc\ub294 \uc5f0\uad6c \ubc94\uc704\uc5d0\uc11c \uc81c\uc678\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \ub9cc\uc131 \ubc0f \ud76c\uadc0 \uc9c8\ud658\uc758 \ubc1c\uc0dd\ub960 \ubc0f \uc720\ubcd1\ub960 \uc99d\uac00, \ud5ec\uc2a4\ucf00\uc5b4 \uc790\uae08 \uc9c0\uc6d0 \ud655\ub300 \ubc0f \ubbfc\uad00 \ud30c\ud2b8\ub108\uc2ed \uac15\ud654, \ub9de\ucda4\ud615 \uc758\ud559 \ucc44\ud0dd \ubc0f \ub3d9\ubc18 \uc9c4\ub2e8 \ud65c\uc6a9 \uc99d\ub300, mRNA \ud50c\ub7ab\ud3fc \uae30\uc220\uc758 \ubc1c\uc804\uc73c\ub85c \uc778\ud55c \uc2e0\uaddc \ubc14\uc774\uc624\uc758\uc57d\ud488 \uac1c\ubc1c \uac00\uc18d\ud654, AI \uae30\ubc18 \ucd08\uae30 \ub2e8\uacc4 \ubc14\uc774\uc624\uc758\uc57d\ud488 \uc124\uacc4 \uc704\ud5d8 \uac10\uc18c, \uadf8\ub9ac\uace0 \uc815\ubd80 \uc8fc\ub3c4\uc758 \ud32c\ub370\ubbf9 \ub300\ube44 \ud504\ub85c\uadf8\ub7a8\uc73c\ub85c \uc778\ud55c \uae00\ub85c\ubc8c \ubc31\uc2e0 \uc81c\uc870 \uc5ed\ub7c9 \ud655\ub300 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc81c\uc57d\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ub192\uc740 \ubc14\uc774\uc624 \uc81c\uc870 \ubc0f \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958 \ube44\uc6a9, \ubcf5\uc7a1\ud558\uace0 \ubcc0\ud654\ubb34\uc30d\ud55c \uae00\ub85c\ubc8c \ubc14\uc774\uc624\uc758\uc57d\ud488 \uaddc\uc81c \ud658\uacbd, \ud575\uc2ec \uc6d0\uc790\uc7ac \uacf5\uae09\ub9dd\uc758 \ucde8\uc57d\uc131, \uadf8\ub9ac\uace0 \ucc28\uc138\ub300 \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc5d0\uc11c \ubc1c\uc0dd\ud560 \uc218 \uc788\ub294 \uba74\uc5ed\uc6d0\uc131 \uc704\ud5d8 \ub4f1\uc774 \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc81c\ud488 \uc720\ud615\ubcc4\ub85c \ubc31\uc2e0(mRNA, \ubc14\uc774\ub7ec\uc2a4 \ubca1\ud130, \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8, \uc811\ud569 \ubc0f \uc11c\ube0c\uc720\ub2db, \uc57d\ub3c5\ud654 \ubc0f \ubd88\ud65c\uc131\ud654 \ubc31\uc2e0), \uce58\ub8cc\uc81c(\ub2e8\uc77c\ud074\ub860 \ud56d\uccb4, \uc7ac\uc870\ud569 \ub2e8\ubc31\uc9c8, \uc720\uc804\uc790 \uce58\ub8cc\uc81c, \uc138\ud3ec \uce58\ub8cc\uc81c, RNA \uce58\ub8cc\uc81c), \uc9c4\ub2e8 \ubc0f \uc5f0\uad6c \ub3c4\uad6c(\uc2dc\ud000\uc2f1 \uc2dc\uc57d \ubc0f \ud0a4\ud2b8, \ub3d9\ubc18 \uc9c4\ub2e8 \ubd84\uc11d, \ud604\uc7a5 \ubd84\uc790 \uac80\uc0ac)\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\ub85c\ub294 \ubc14\uc774\uc624\uc81c\uc57d \uae30\uc5c5, \uc704\ud0c1\uc0dd\uc0b0\uae30\uad00(CMO), \uc704\ud0c1\uc5f0\uad6c\uae30\uad00(CRO), \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00, \ubcd1\uc6d0 \ubc0f \uc804\ubb38 \ud074\ub9ac\ub2c9\uc73c\ub85c \ub098\ub258\uba70, \uc9c0\ub9ac\uc801\uc73c\ub85c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8 \ub4f1 \uc8fc\uc694 \uc9c0\uc5ed \ubc0f \uad6d\uac00\ubcc4\ub85c \uc0c1\uc138\ud558\uac8c \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 Amgen, AstraZeneca, BioNTech, F. Hoffmann-La Roche, Johnson &#038; Johnson, Lonza Group, Merck &#038; Co., Moderna, Novartis, Pfizer, Sanofi, Thermo Fisher Scientific \ub4f1 \uc8fc\uc694 \uae00\ub85c\ubc8c \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud30c\uc77c\uacfc \uc2dc\uc7a5 \uc810\uc720\uc728, \uc804\ub7b5\uc801 \uc815\ubcf4 \ub4f1\uc774 \ub2e4\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5\uc758 \uc8fc\uc694 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud558\uba70, \ub2e4\uc74c\uacfc \uac19\uc740 \ud575\uc2ec \uc9c8\ubb38\uc5d0 \ub300\ud55c \ud1b5\ucc30\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\ub294 FDA\uc758 \ud76c\uadc0 \uc9c8\ud658 \ud601\uc2e0 \ud5c8\ube0c \ud504\ub85c\uadf8\ub7a8\uacfc \uac19\uc740 \uac00\uc18d\ud654\ub41c \uac80\ud1a0\ub97c \ud1b5\ud574 \uac00\uc7a5 \ube60\ub974\uac8c \uaddc\uc81c \uc2b9\uc778\uc744 \ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc778\uacf5\uc9c0\ub2a5\uc740 \ub2e8\ubc31\uc9c8 \uc811\ud798 \ubc0f \uba74\uc5ed\uc6d0\uc131 \ud56b\uc2a4\ud31f\uc744 \uc608\uce21\ud558\uc5ec \ucd08\uae30 \ub2e8\uacc4 \uac1c\ubc1c \uc704\ud5d8\uc744 \uc904\uc774\uba70 \ubc14\uc774\uc624\uc758\uc57d\ud488 \ubc1c\uacac \ubc0f \uac1c\ubc1c\uc744 \ud601\uc2e0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. CMO\ub294 \uc790\ubcf8 \uc9c0\ucd9c \uc5c6\uc774 \uc0dd\uc0b0 \uaddc\ubaa8\ub97c \ud655\uc7a5\ud558\uace0 \uc2e0\uc18d\ud55c \uc0c1\uc5c5\uc801 \ucd9c\uc2dc\ub97c \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \ubc14\uc774\uc624\uc81c\uc57d \uae30\uc5c5\uc5d0 \uc804\ub7b5\uc801 \uc774\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ubcc0\ud654\ud558\ub294 \uae00\ub85c\ubc8c \uaddc\uc81c(\uc608: 2025\ub144 \uc774\ud6c4 EU \ubc0f \ubbf8\uad6d \uaddc\uc815)\ub294 \uae30\uc5c5\ub4e4\uc774 \uc9c0\uc5ed\ubcc4 \uc81c\ucd9c \ubc0f \ube0c\ub9ac\uc9d5 \uc5f0\uad6c\ub97c \uc218\ud589\ud558\ub3c4\ub85d \uc720\ub3c4\ud558\uba70 \uc2dc\uc7a5 \uc9c4\uc785 \uc804\ub7b5\uc5d0 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4. \ub9de\ucda4\ud615 \uc758\ud559\uc758 \ubd80\uc0c1\uc740 \ub3d9\ubc18 \uc9c4\ub2e8\uc744 \ud604\uc7a5 \uc9c4\ub8cc\uc5d0 \ub354 \uac00\uae5d\uac8c \ud1b5\ud569\ud558\uc5ec \uc784\uc0c1\uc758\uac00 \ucd08\uae30 \ud658\uc790 \ubc29\ubb38 \uc2dc \ud45c\uc801 \uce58\ub8cc\ubc95\uc744 \uc120\ud0dd\ud558\ub3c4\ub85d \ub3d5\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub9c8\uc9c0\ub9c9\uc73c\ub85c, \ud2b8\ub79c\uc2a4 \uc99d\ud3ed mRNA \ubc31\uc2e0 \ubc0f \ucc28\uc138\ub300 \uc548\uc815\ud654 \ubd80\ud615\uc81c\uc640 \uac19\uc740 \uae30\uc220 \ubc1c\uc804\uc740 \ud45c\uc900 \ub0c9\uc7a5 \ubcf4\uad00\uc5d0\uc11c \uc81c\ud488 \uc720\ud1b5\uae30\ud55c\uc744 \uc5f0\uc7a5\ud558\uc5ec \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958 \ube44\uc6a9\uc744 \uc808\uac10\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\uc758 \uc5f0\uad6c \ubc29\ubc95\ub860\uc740 1\ucc28 \ubc0f 2\ucc28 \uc5f0\uad6c\ub97c \uae30\ubc18\uc73c\ub85c \ud558\uba70, \ubc14\uc774\uc624\uc81c\uc57d \uae30\uc5c5\uc758 \uc81c\uc870 \ucc45\uc784\uc790, CMO\uc758 \uc870\ub2ec \ucc45\uc784\uc790, \uc885\uc591 \uc804\ubb38\uc758 \ub4f1\uacfc\uc758 \uc778\ud130\ubdf0\ub97c \ud1b5\ud574 \ub370\uc774\ud130\ub97c \uac80\uc99d\ud569\ub2c8\ub2e4. \ub610\ud55c FDA, EMA, WHO \ub4f1\uc758 \uacf5\uacf5 \ub370\uc774\ud130\uc640 \uc720\ub8cc \ud50c\ub7ab\ud3fc\uc744 \ud65c\uc6a9\ud55c \uc2ec\uce35\uc801\uc778 \ub370\uc2a4\ud06c \ub9ac\uc11c\uce58\ub97c \uc218\ud589\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \uc0b0\uc815 \ubc0f \uc608\uce21\uc740 \uc0c1\ud5a5\uc2dd \ubc0f \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd\uc744 \uacb0\ud569\ud558\uace0, R&#038;D \uc9c0\ucd9c, \uc2b9\uc778\ub41c \uc801\uc751\uc99d \uc218, \ubc14\uc774\uc624\ub9ac\uc561\ud130 \ud65c\uc6a9\ub960 \ub4f1 \ub2e4\uc591\ud55c \ubcc0\uc218\ub97c \uace0\ub824\ud55c \ub2e4\ubcc0\ub7c9 \ud68c\uadc0 \ubd84\uc11d\uc744 \ud1b5\ud574 2030\ub144\uae4c\uc9c0\uc758 \uac00\uce58\ub97c \uc608\uce21\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc5c4\uaca9\ud558\uace0 \uc5f0\uac04 \uc5c5\ub370\uc774\ud2b8\ub418\ub294 \ubc29\ubc95\ub860\uc740 \ubcf4\uace0\uc11c\uc758 \uc2e0\ub8b0\uc131\uc744 \ub192\uc785\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-59419","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/59419"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=59419"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/59419\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=59419"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=59419"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=59419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}